Atomic Invest LLC’s AbbVie ABBV Stock Holding History

Atomic Invest LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$37.4K	Buy	+163	New	+$37.1K	0.02%	102

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Atomic Invest LLC's ABBV Position: Q4 2025 in Review

Atomic Invest LLC opened a new position in AbbVie (ABBV) in Q4 2025: 163 shares worth $37.4K. The stake represents 0.02% of the portfolio and ranks #102 among its holdings.

4,168 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Atomic Invest LLC held 163 shares of AbbVie worth $37.4K as of Q4 2025.
AbbVie was a new Atomic Invest LLC position in Q4 2025.
AbbVie made up 0.02% of Atomic Invest LLC's portfolio in Q4 2025, its #102 holding.
4,168 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Atomic Invest LLC's 13F filing for Q4 2025, filed 18 Sep 2026.